A central nervous system stimulant. It was formerly used in the treatment of barbiturate overdose but is now considered to be of no value for such purposes and may be dangerous. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1229)
Nikethamide has been studied across 13 research domains including 🫁 Respiratory, 😴 Sleep, ❤️ Cardiovascular, 🫁 Liver & Detox, 🧠 Focus & Attention. The primary research focus is 🫁 Respiratory with 14% of studies addressing this area.
This evidence profile for Nikethamide is generated deterministically from 262 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.